Bank of New York Mellon’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-133,680
| Closed | -$247K | – | 4513 |
|
|
2023
Q1 | $247K | Hold |
133,680
| – | – | ﹤0.01% | 3828 |
|
|
2022
Q4 | $148K | Sell |
133,680
-11,020
| -8% | -$12.2K | ﹤0.01% | 4056 |
|
|
2022
Q3 | $339K | Buy |
144,700
+18,290
| +14% | +$42.8K | ﹤0.01% | 3770 |
|
|
2022
Q2 | $383K | Sell |
126,410
-842
| -0.7% | -$2.55K | ﹤0.01% | 3751 |
|
|
2022
Q1 | $865K | Buy |
127,252
+247
| +0.2% | +$1.68K | ﹤0.01% | 3402 |
|
|
2021
Q4 | $1.06M | Sell |
127,005
-1,074
| -0.8% | -$8.98K | ﹤0.01% | 3345 |
|
|
2021
Q3 | $952K | Buy |
128,079
+25,811
| +25% | +$192K | ﹤0.01% | 3420 |
|
|
2021
Q2 | $695K | Buy |
102,268
+31,097
| +44% | +$211K | ﹤0.01% | 3610 |
|
|
2021
Q1 | $731K | Sell |
71,171
-869
| -1% | -$8.93K | ﹤0.01% | 3496 |
|
|
2020
Q4 | $504K | Sell |
72,040
-114,247
| -61% | -$799K | ﹤0.01% | 3613 |
|
|
2020
Q3 | $1.52M | Sell |
186,287
-14,363
| -7% | -$117K | ﹤0.01% | 2845 |
|
|
2020
Q2 | $1.39M | Sell |
200,650
-8,357
| -4% | -$57.7K | ﹤0.01% | 2908 |
|
|
2020
Q1 | $993K | Sell |
209,007
-11,124
| -5% | -$52.9K | ﹤0.01% | 2985 |
|
|
2019
Q4 | $1.92M | Buy |
220,131
+134,965
| +158% | +$1.18M | ﹤0.01% | 2840 |
|
|
2019
Q3 | $284K | Buy |
85,166
+145
| +0.2% | +$484 | ﹤0.01% | 3793 |
|
|
2019
Q2 | $421K | Buy |
85,021
+17,218
| +25% | +$85.3K | ﹤0.01% | 3677 |
|
|
2019
Q1 | $420K | Sell |
67,803
-1,265
| -2% | -$7.84K | ﹤0.01% | 3622 |
|
|
2018
Q4 | $233K | Buy |
69,068
+21,475
| +45% | +$72.4K | ﹤0.01% | 3800 |
|
|
2018
Q3 | $309K | Buy |
47,593
+25
| +0.1% | +$162 | ﹤0.01% | 3809 |
|
|
2018
Q2 | $365K | Sell |
47,568
-1,072
| -2% | -$8.23K | ﹤0.01% | 3767 |
|
|
2018
Q1 | $1.09M | Buy |
48,640
+2,751
| +6% | +$61.5K | ﹤0.01% | 3168 |
|
|
2017
Q4 | $585K | Buy |
45,889
+4,467
| +11% | +$56.9K | ﹤0.01% | 3531 |
|
|
2017
Q3 | $646K | Buy |
41,422
+15,848
| +62% | +$247K | ﹤0.01% | 3458 |
|
|
2017
Q2 | $359K | Buy |
25,574
+8,063
| +46% | +$113K | ﹤0.01% | 3744 |
|
|
2017
Q1 | $385K | Buy |
+17,511
| New | +$385K | ﹤0.01% | 3657 |
|